跳至主要内容
临床试验/JPRN-C000000049
JPRN-C000000049已完成未知

A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401) - Transarterial chemoembolization with cisplatin for hepatocellular carcinoma(JIVROSG-0401)

Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 个研究点目标入组 60 人开始时间: 2005年8月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Prior chemotherapy with cisplatin for HCC. 2) Suspicious of extra-hepatic arterial blood supply to lesions on contrast-enhanced CT. 3) Extra-hepatic arterial blood supply to lesions on prior angiography. 4) Surgical reconstruction or endoscopic treatment involving biliary system. 5) Lymphnode metastasis or distant metastasis. 6) Other uncontrolled severe illness. 7) Active infectious disease except viral hepatitis. 8) Active other malignancies. 9) Allergic reaction to iodine contrast material, platinum containing agent, or gelatin containing agent. 10) Pregnant or nursing.

研究者

发起方
Japan Interventional Radiology in Oncology Study Group (JIVROSG)

相似试验

已完成
1 期
Phase I study of transarterial chemoembolization using Cisplatin powder and miriplatin in patients with hepatocellular carcinomahepatocellular carcinoma
JPRN-UMIN000010431Southern TOHOKU General Hospital10
进行中(未招募)
不适用
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectable
EUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf
已完成
2 期
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinoma
JPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24
已完成
1 期
Phase I/II study of transcatheter arterial chemo-embolization with DDP-H and degradable starch microspheres for hepatic metastases of colorectal cancerColorectal Cancer
JPRN-UMIN000001168Radiology, Nara Medical University Hospital27
已完成
2 期
PhaseII study of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma -Compared with retrospective historical cohort study with epirubicin hydrochlorideHepatocellular carcinoma
JPRN-UMIN000005229ara Medical University, Department of Radiology33